Cargando…

Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition

Detalles Bibliográficos
Autor principal: Fernandes, Ana I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674154/
https://www.ncbi.nlm.nih.gov/pubmed/38004582
http://dx.doi.org/10.3390/pharmaceutics15112604
_version_ 1785140761674645504
author Fernandes, Ana I.
author_facet Fernandes, Ana I.
author_sort Fernandes, Ana I.
collection PubMed
description
format Online
Article
Text
id pubmed-10674154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106741542023-11-08 Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition Fernandes, Ana I. Pharmaceutics Editorial MDPI 2023-11-08 /pmc/articles/PMC10674154/ /pubmed/38004582 http://dx.doi.org/10.3390/pharmaceutics15112604 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Fernandes, Ana I.
Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title_full Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title_fullStr Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title_full_unstemmed Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title_short Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
title_sort polymers enhancing bioavailability in drug delivery, 2nd edition
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674154/
https://www.ncbi.nlm.nih.gov/pubmed/38004582
http://dx.doi.org/10.3390/pharmaceutics15112604
work_keys_str_mv AT fernandesanai polymersenhancingbioavailabilityindrugdelivery2ndedition